Q1 2025 Earnings Conference Call May 15, 2025 4:30 PM ETCompany ParticipantsBryan Giraudo - COO & CFOFaheem Hasnain ...

Belite Bio Inc (BLTE) showcases promising trial progress and a robust cash runway, despite increased R&D and G&A expenses leading to a higher net loss.

Q1 2025 Management View CEO Tom Lin reported continued progress in advancing Tinlarebant for Stargardt's disease and ...

Biomed Israel 2025: the 23rd National Life Science & Technology Week is taking place in Tel Aviv, between 20 and 22 May.

It's perfectly normal to make a spreadsheet of all your 'Tears of the Kingdom' armors and how to upgrade them, right? Well, ...

Renewable naphtha has gained steady attention as a sustainable alternative to fossil-based naphtha in the petrochemical ...

Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced its financial ...

Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet ...

The global forestry lubricants market share analysis is rapidly evolving, driven by the increasing demand for environmentally friendly solutions and the need for enhanced equipment efficiency. A ...

Bio-Techne is a market leader in proteins, immunoassays, clinical diagnostic controls, and other reagents that are crucial for the academic, biopharmaceutical, and diagnostic markets.

See the Gatekeeper policy library for a collection of constraint templates and sample constraints that you can use with Gatekeeper.